Literature DB >> 17717933

[Application of central randomized system in project of clinical trial for secondary prevention of myocardial infarction by Qishen Yiqi Drop Pill].

Guo-hua Dai1, Bo-li Zhang, Zhi-xin Guo.   

Abstract

Central randomized system (CRS) is actually a management system for actualizing process of clinical trial, which can not only reduce the factitious jamming during randomization to avoid bias, but also play an important role in drug supervision during long-term and large-scale clinical trials in which a large amount of drugs are applied. This article introduced the two main functions of the CRS, i. e. the randomization of testees and the management of drugs, as well as the key points and instructions for applying clinical research interactive voice responding system (CRIVRS) in operating the project of clinical trial for secondary prevention of myocardial infarction by Qishen Yiqi Drop Pill.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717933

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  6 in total

1.  Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease.

Authors:  Yong Wang; Zhongyang Liu; Chun Li; Dong Li; Yulin Ouyang; Junda Yu; Shuzhen Guo; Fuchu He; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-08       Impact factor: 2.629

2.  Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway.

Authors:  Chun Li; Yong Wang; Qi Qiu; Tianjiao Shi; Yan Wu; Jing Han; Xingyun Chai; Wei Wang
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

3.  Simultaneous Determination of Twenty-Five Compounds in Rat Plasma Using Ultra-High Performance Liquid Chromatography-Polarity Switching Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study.

Authors:  Na Zhang; Yueting Li; Jing Sun; Chun Li; Yuelin Song; Jun Li; Pengfei Tu; Yunfang Zhao
Journal:  Molecules       Date:  2017-10-30       Impact factor: 4.411

4.  QSYQ Attenuates Oxidative Stress and Apoptosis Induced Heart Remodeling Rats through Different Subtypes of NADPH-Oxidase.

Authors:  Yong Wang; Chun Li; Yuli Ouyang; Tianjiao Shi; Xiaomin Yang; Junda Yu; Qi Qiu; Jing Han; Yan Wu; Binghua Tang; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

5.  Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2.

Authors:  Yong Wang; Chun Li; Yulin Ouyang; Junda Yu; Shuzhen Guo; Zhongyang Liu; Dong Li; Jing Han; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-13       Impact factor: 2.629

6.  Time-Course of the Effects of QSYQ in Promoting Heart Function in Ameroid Constrictor-Induced Myocardial Ischemia Pigs.

Authors:  Qi Qiu; Yang Lin; Cheng Xiao; Chun Li; Yong Wang; Kexu Yang; Wei Suo; Yu Li; Wenjing Chuo; Yongxiang Wei; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-10       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.